SCHEMBL31225865

SCHEMBL31225865

O=C(Cc1ccc(Cl)cc1)NC[C@@H](O)[C@@H](O)C1OC(C(=O)O)CC(O)C1NC(=O)CO

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD22 P20273 15/20 0.51
▸ MAG P20916 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31226058 0.92 CD22 (0.43) CD22MAG
SCHEMBL31527623 0.89 CD22 (0.56) CD22MAG
SCHEMBL31527622 0.82 CD22 (0.47) CD22MAG
SCHEMBL31225429 0.78 POLB (0.39) CD22
SCHEMBL24630056 0.78 NEU1 (0.40) —
SCHEMBL31225617 0.75 CD22 (0.54) CD22MAG
SCHEMBL31225230 0.75 CD22 (0.67) CD22MAG
SCHEMBL31225175 0.75 CD22 (0.54) CD22MAG
SCHEMBL31225838 0.75 CD22 (0.67) CD22MAG
SCHEMBL31225456 0.74 CD22 (0.53) CD22MAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727537-A2 SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF Adaxion Therapeutics, Inc. (US) 2026-04-22 — — EP disclosed
WO-2024259007-A2 SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF OSPREY BIOPHARMACEUTICALS, INC. (US) 2024-12-19 — — WO disclosed
Send feedback